Pamidronate

CHronic Nonbacterial Osteomyelitis International Registry

Effect of Local Pamidronate in Preventing Bone Loss After Total Hip Arthroplasty

Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation

Prevention of Post Operative Bone Loss in Children

Pamidronate Administration in Breast Cancer Patients With Bone Metastases

4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases

Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation

Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain

The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer

Bisphosphonate Therapy for Osteogenesis Imperfecta

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial

Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease

Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression

Efficiency and Safety Study of Pamidronate in Inflammatory Back Pain Due to Degenerative Disk Disease

A Pilot Trial of IV Pamidronate for Low Back Pain

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.

A Pilot Trial of Intravenous (IV) Pamidronate for Low Back Pain

Osteopenia and Renal Osteodystrophy: Evaluation and Management